LONDON (Reuters) - The first vaccine against meningitis B has been recommended for approval in Europe in a boost for its maker Novartis, which has struggled in the vaccines field against larger rivals ...
ZURICH (Reuters) - Novartis clinched European approval for the first vaccine against meningitis B, and will seek to sell the drug as soon as possible. "Novartis is working with health authorities to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback